Veraxa Biotech AG shares data on BiTAC-ADC tech
- Presented in vivo proof-of-concept data on Oct 13, 2026
- Released additional in vitro data on BiTAC-ADC platform
- Press release attached as Exhibit 99.1
VRXAW
Veraxa Biotech AG - Post de-SPAC SEC filings
Every EDGAR filing for Veraxa Biotech AG - Post de-SPAC (VRXAW), newest first, with AI summaries and stories.
- Ticker
- VRXAW
- CIK
- 2079109
- Latest filing
- 3d
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE6-KVeraxa Biotech AG - Post de-SPACVRXAWLIVE ROUTINE3Veraxa Biotech AG - Post de-SPACVRXAWLIVE Raju Sudir Willener, new insider at VRXAW
Raju Sudir Willener, reporting
ROUTINE6-KVeraxa Biotech AG - Post de-SPACVRXAWLIVE ROUTINE424B3Veraxa Biotech AG - Post de-SPACVRXAWLIVE 2 structured-note prospectuses
Securities offering
Show all 2
- 424B3Securities offering
- 424B3Securities offering
ROUTINE4Veraxa Biotech AG - Post de-SPACVRXAWLIVE 2 insider filings
Christoph Rudiger Antz, insider filing for VRXAW
Show all 2
- 4Insider filing for VRXAW
- 4Insider filing for VRXAW
Christoph Rudiger Antz, reporting
ROUTINE6-KVeraxa Biotech AG - Post de-SPACVRXAWLIVE ROUTINE3Veraxa Biotech AG - Post de-SPACVRXAWLIVE Halem Carl von, new insider at VRXAW
Halem Carl von, reporting
ROUTINESCHEDULE 13G/AVeraxa Biotech Holding AGVRXAWLIVE Ownership stake disclosure by AQR CAPITAL MANAGEMENT LLC (amended)
AQR CAPITAL MANAGEMENT LLC, filed by
ROUTINE424B5Veraxa Biotech Holding AGVRXAWLIVE 2 structured-note prospectuses
Securities offering
Show all 2
- 424B5Securities offering
- 424B5Securities offering
ROUTINEEFFECTVeraxa Biotech Holding AGVRXAWLIVE ROUTINEEFFECTVeraxa Biotech Holding AGVRXAWLIVE ROUTINEF-1/AVeraxa Biotech Holding AGVRXAWLIVE ROUTINEF-1/AVeraxa Biotech Holding AGVRXAWLIVE NOTABLEF-1Veraxa Biotech Holding AGVRXAWLIVE NOTABLEF-1Veraxa Biotech Holding AGVRXAWLIVE ROUTINE6-KVeraxa Biotech Holding AGVRXAWLIVE ROUTINE6-KVeraxa Biotech Holding AGVRXAWLIVE ROUTINE6-KVeraxa Biotech Holding AGVRXAWLIVE ROUTINE6-KVeraxa Biotech Holding AGVRXAWLIVE NOTABLE20-FVeraxa Biotech Holding AGVRXAWLIVE NOTABLESCHEDULE 13DVeraxa Biotech Holding AGVRXAWLIVE Ownership stake disclosure by Molecular Biology Laboratory European
Molecular Biology Laboratory European, filed by
NOTABLESCHEDULE 13DVeraxa Biotech Holding AGVRXAWLIVE Ownership stake disclosure by David Lukas Deck
David Lukas Deck, filed by
NOTABLESCHEDULE 13DVeraxa Biotech Holding AGVRXALIVE Ownership stake disclosure by Xlife Sciences AG
Xlife Sciences AG, filed by
NOTABLESCHEDULE 13DVeraxa Biotech Holding AGVRXALIVE Ownership stake disclosure by Gilbert Edgar Schoeni
Gilbert Edgar Schoeni, filed by
ROUTINECERTVeraxa Biotech Holding AGVRXALIVE ROUTINE8-A12B/AVeraxa Biotech Holding AGVRXALIVE ROUTINE3Veraxa Biotech Holding AGVRXALIVE 2 insider filings
Marc Gruninger, new insider at VRXA
Show all 2
- 3New insider at VRXA
- 3New insider at VRXA
Marc Gruninger, reporting
ROUTINE3Veraxa Biotech Holding AGVRXALIVE Warren Hosseinion, new insider at VRXA
Warren Hosseinion, reporting
ROUTINE3Veraxa Biotech Holding AGVRXALIVE 4 insider filings
Oliver Rolf Baumann, new insider at VRXA
Show all 4
- 3New insider at VRXA
- 3New insider at VRXA
- 3New insider at VRXA
- 3New insider at VRXA
Oliver Rolf Baumann, reporting
ROUTINE8-A12BVeraxa Biotech Holding AGVRXALIVE ROUTINE424B3Voyager Acquisition Corp./Cayman IslandsVACHWLIVE Veraxa Biotech Holding AG, filer · Veraxa Biotech AG, filer
ROUTINEF-4/AVoyager Acquisition Corp./Cayman IslandsVACHWLIVE Veraxa Biotech Holding AG, filer · Veraxa Biotech AG, filer
ROUTINEF-4/AVoyager Acquisition Corp./Cayman IslandsVACHWLIVE Veraxa Biotech Holding AG, filer · Veraxa Biotech AG, filer